Suppression of Expression of Heat Shock Protein 70 by Gefitinib and Its Contribution to Pulmonary Fibrosis

Drug-induced interstitial lung disease (ILD), particularly pulmonary fibrosis, is of serious clinical concern. Gefitinib, a tyrosine kinase inhibitor of the epidermal growth factor receptor (EGFR), is beneficial as a drug for treating non-small cell lung cancer; however, this drug induces ILD and th...

Descripción completa

Detalles Bibliográficos
Autores principales: Namba, Takushi, Tanaka, Ken-Ichiro, Hoshino, Tatsuya, Azuma, Arata, Mizushima, Tohru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212557/
https://www.ncbi.nlm.nih.gov/pubmed/22096546
http://dx.doi.org/10.1371/journal.pone.0027296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212557/
https://www.ncbi.nlm.nih.gov/pubmed/22096546
http://dx.doi.org/10.1371/journal.pone.0027296

Ejemplares similares